Logo image
Cannabinoid agonist administration within the cerebellar cortex impairs motor learning
Journal article   Peer reviewed

Cannabinoid agonist administration within the cerebellar cortex impairs motor learning

Adam B Steinmetz and John H Freeman
Neurobiology of learning and memory, Vol.170, pp.106896-106896
04/2020
DOI: 10.1016/j.nlm.2018.06.015
PMCID: PMC6311437
PMID: 29964164
url
https://www.ncbi.nlm.nih.gov/pmc/articles/6311437View
Open Access

Abstract

Systemic administration of cannabinoid agonists impairs cerebellum-dependent motor learning. The cannabinoid-induced impairment of motor learning has been hypothesized to be due to disruption of Purkinje cell plasticity within the cerebellar cortex. In the current study, we tested this hypothesis in rats with localized microinfusions of cannabinoid agonists and antagonists into the cerebellar cortex during eyeblink conditioning, a type of cerebellum-dependent motor learning. Infusions of the cannabinoid agonists WIN55,212-2 or ACEA directly into the eyeblink conditioning microzone of the cerebellar cortex severely impaired acquisition of eyeblink conditioning, whereas the CB1R antagonist SR141716A did not produce a significant impairment. Infusions of WIN55,212-2 outside of the eyeblink conditioning microzone did not impair motor learning, establishing anatomical specificity for the agonist effects. The motor learning impairment caused by WIN55,212-2 and ACEA was rescued by SR141716A, indicating that the learning deficit was produced through CB1Rs. The current findings demonstrate that the effects of cannabinoid receptor agonists on motor learning are localized to CB1Rs within a discrete microzone of the cerebellar cortex.
Conditioning, Eyelid - physiology Animals Rats, Long-Evans Cerebellum - drug effects Male Cerebellum - physiology Cannabinoid Receptor Agonists - administration & dosage Receptor, Cannabinoid, CB1 - physiology Conditioning, Eyelid - drug effects

Details

Metrics

Logo image